Astrazen Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Panchkula, Haryana, India, established in 2020.
2020 Panchkula, Haryana, India Active
Last Updated:
Access Report
About Astrazen Pharmaceuticals Private Limited

Astrazen Pharmaceuticals Private Limited, a active private limited company, was established on 13 October 2020 in Panchkula, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290HR2020PTC090053. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Shailja Tiwari (Director), Paras Nath Tiwary (Director), Nirmal Kumar Nirala (Director). Past directors included Shailja Tiwari, Paras Nath Tiwary, Nirmal Kumar Nirala. It holds ₹1.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House 547, Sector 12A, Panchkula, Haryana, 134113.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290HR2020PTC090053

  • Registration Number

    090053

  • Incorporation Date

    13 October 2020

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.25 Cr
  • Revenue Growth **** 905.50%
  • Profit Growth **** 191.75%
  • Ebitda **** 235.31%
  • Net Worth 9.06%
  • Total Assets **** 52.07%
Company report

Astrazen Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Astrazen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Astrazen Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shailja Tiwari Director 14 Mar 2023 Current
Paras Nath Tiwary Director 16 Dec 2022 Current
Nirmal Kumar Nirala Director 27 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 14 Mar 2023 Past
Pramod Abcsdd Director 16 Dec 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Astrazen Pharmaceuticals.

Astrazen Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 905.5% increase. The company also saw a substantial improvement in profitability, with a 191.75% increase in profit. The company's net worth moved up by a moderate rise of 9.06%.

Astrazen Pharmaceuticals revenue growth over time
Astrazen Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 905.50%
*******
*******
*******
*******
Revenue from Operations
*******
 1029.19%
*******
*******
*******
*******
Total Assets
*******
 52.07%
*******
*******
*******
*******
Profit or Loss
*******
 191.75%
*******
*******
*******
*******
Net Worth
*******
 9.06%
*******
*******
*******
*******
EBITDA
*******
 235.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Astrazen Pharmaceuticals?

Unlock access to Astrazen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹12,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.25 Cr
Latest Charge Details
Date Lender Amount Status
21 Apr 2021 Canara Bank ₹1.25 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Astrazen Pharmaceuticals?

Astrazen Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Astrazen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrazen Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Astrazen Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Astrazen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Astrazen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Nirmal Kumar Nirala was appointed as a Director was appointed as a Director on 27 Dec 2023 & has been associated with this company since 2 years 1 month . was completed.

  • Charges

    Progress on A charge with Canara Bank of Rs. 12.50 M registered on 21 Apr 2021 with Charge ID 100457498 was modified on 05 May 2023. was documented.

  • Director Appointment

    Progress on Shailja Tiwari was appointed as a Director was appointed as a Director on 14 Mar 2023 & has been associated with this company since 2 years 11 months . was documented.

  • Director Appointment

    Progress on Paras Nath Tiwary was appointed as a Director was appointed as a Director on 16 Dec 2022 & has been associated with this company since 3 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Astrazen Pharmaceuticals Private Limited?

The CIN of Astrazen Pharmaceuticals Private Limited is U24290HR2020PTC090053.

Where is Astrazen Pharmaceuticals Private Limited headquartered?

Astrazen Pharmaceuticals Private Limited is headquartered at House 547, Sector 12A, Panchkula, Haryana, 134113.

When was Astrazen Pharmaceuticals Private Limited incorporated?

Astrazen Pharmaceuticals Private Limited was incorporated on 13 October 2020.

Who are the current directors of Astrazen Pharmaceuticals Private Limited?

The current directors of Astrazen Pharmaceuticals Private Limited are

What is the primary industry of Astrazen Pharmaceuticals Private Limited?

The primary industry of Astrazen Pharmaceuticals Private Limited is Manufacturing.

Is Astrazen Pharmaceuticals Private Limited a listed company?

Astrazen Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Astrazen Pharmaceuticals Private Limited?

The authorized capital of Astrazen Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Astrazen Pharmaceuticals Private Limited?

The compliance status of Astrazen Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available